| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 04/28/2005 | WO2005014517A3 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/28/2005 | US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer |
| 04/28/2005 | US20050090524 Novel adamantane derivatives |
| 04/28/2005 | US20050089793 a photoresist composition of a polyether; a diphenyl propenol polymerized with epichlorhydrin, an acrylate resin, a curing agent, and an organic solvent; a high curing efficiency, brightness; prevents the formation of remnant in photoresist patterns |
| 04/28/2005 | US20050089584 Nut extract having different alkaloid profile; reduced level of carcinogens; supercritical CO2 extraction; maintaining nutraceutical effects; rapidly dissolving tablets |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/27/2005 | CN1198806C Oxodiethylenediamine derivative and light stabilized composition |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884758 2,4-Diamino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | WO2005035504A2 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/21/2005 | WO2005034960A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 04/21/2005 | CA2541667A1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/21/2005 | CA2541590A1 Treatment of diseases associated with the egr-1 enhancer element |
| 04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | CA2526017A1 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/14/2005 | WO2005033070A2 Method for the production of bisepoxides and dithiols |
| 04/14/2005 | WO2004013120A8 Novel benzodioxoles |
| 04/14/2005 | CA2539748A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/12/2005 | US6878834 Selectively reduced to the corresponding hydroxy group |
| 04/12/2005 | US6878833 Tetraalkylammonium alkoxides |
| 04/12/2005 | US6878727 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050075325 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders |
| 04/07/2005 | US20050075269 Substituted benzofuran-2-carboxamides derivatives |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2539471A1 Carbamoyl-type benzofuran derivatives |
| 03/31/2005 | US20050069715 A curable compound, or adduct, or epoxy resins of anthrahydroquinone and epichlorohydrin; phenolic resin as curing agents; cured product is used for semiconductor encapsulation; solid, low melt viscosity, flame retardance, halogen-free; mechanical strength, heat resistance, moisture resistance |
| 03/31/2005 | US20050069596 Compositions and methods comprising kava and anti-anxiety compounds |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2539162A1 Cinnamoyl derivatives and use thereof |
| 03/30/2005 | EP1517895A1 8-(biaryl) quinoline pde4 inhibitors |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872842 Butenyl substituted taxanes |
| 03/29/2005 | US6872839 Stabilizers; heat resistance, colorfastness, photostability |
| 03/29/2005 | US6872837 Taxanes having a c10 Heterosubstituted acetate substituent |
| 03/29/2005 | US6872735 LFA-1 antagonist compounds |
| 03/24/2005 | WO2005026163A1 Dioxolane derivatives as cell adhesion inhibitors |
| 03/24/2005 | WO2005026143A1 Coumarins as inos inhibitors |
| 03/24/2005 | US20050065353 Mitosis agents; antitumor agents; anticancer agents |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | EP1515966A1 Hydroxy pyranone derivative and preparation method thereof |
| 03/23/2005 | EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 03/23/2005 | EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 03/22/2005 | US6870058 Polyhydroxy, dienyl lactones and intermediates |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 03/17/2005 | WO2004072033A3 Pyrazoles and methods of making and using the same |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | DE10337863A1 Verwendung von Chromen-4-on-Derivaten The use of chromene-4-one derivatives |
| 03/17/2005 | CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 03/16/2005 | CN1596251A Piperazine derivatives having SST1 antagonistic activity |
| 03/16/2005 | CN1594315A Novel process for preparation of silybum mariamum extractive methylglucamine |
| 03/16/2005 | CN1193028C Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof |
| 03/16/2005 | CN1193027C Substituted pyrroles |
| 03/15/2005 | US6867321 Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867230 Antibacterial and antiprotozoal agents |
| 03/15/2005 | US6867200 Anticancer agents; anticoagulants |
| 03/10/2005 | WO2005020981A1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 03/10/2005 | WO2004071447B1 Substituted azole derivatives as therapeutic agents |
| 03/10/2005 | US20050054721 3-Aryl-4-Hydroxyfuranone compounds and the human and animal health use thereof |
| 03/10/2005 | US20050054718 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency |
| 03/10/2005 | US20050054717 Coumarin derivative |
| 03/10/2005 | US20050054681 Coumarins as iNOS inhibitors |
| 03/10/2005 | US20050054668 Antagonists of MCP-1 function and methods of use thereof |
| 03/10/2005 | US20050054629 Antiproliferative agents; anticancer agents; restenosis |
| 03/10/2005 | US20050053678 Methods and compositions for betel nut chewing gum |
| 03/09/2005 | EP1511734A2 Compounds, compositions, and methods |
| 03/09/2005 | EP1345892B1 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 03/09/2005 | CN1592746A LFA-1 antagonist compounds |
| 03/09/2005 | CN1592618A Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 03/09/2005 | CN1590386A Sidechain-bearing taxanes and method for the preparation thereof |
| 03/09/2005 | CN1192031C Epothilones derivatives, their synthesis and uses |
| 03/09/2005 | CN1192027C Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864279 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs |
| 03/08/2005 | US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 03/03/2005 | WO2005019196A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
| 03/03/2005 | US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 03/03/2005 | DE102004021338A1 New pyran compounds are useful as components in liquid crystalline media, preferably in optoelectronic displays |
| 03/03/2005 | CA2533396A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/01/2005 | US6861446 C7 heterosubstituted acetate taxane compositions |